tisagenlecleucel

Italy

Drugs containing this active substance

  • KYMRIAH

    It is used to treat B-cell acute lymphoblastic leukaemia in children and young adults up to 25 years of age (when the cancer does not respond to treatments or recurs), diffuse large B-cell lymphoma in adults, and follicular lymphoma in adults, when these have not responded to two or more previous treatments.

    Form: solution for infusion

    Active substance Dosage
    tisagenlecleucel -

    ATC: L01XL04

    Manufacturer: NOVARTIS EUROPHARM LIMITED